SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-130805
Filing Date
2024-12-20
Accepted
2024-12-20 16:05:24
Documents
14
Period of Report
2024-12-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431750d1_8k.htm   iXBRL 8-K 28838
2 EXHIBIT 3.1 tm2431750d1_ex3-1.htm EX-3.1 5963
  Complete submission text file 0001104659-24-130805.txt   213839

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aeon-20241218.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeon-20241218_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeon-20241218_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2431750d1_8k_htm.xml XML 3924
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 241567926
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)